Oropharyngeal Cancers Withdrawn Phase 1 / 2 Trials for Alpelisib (DB12015)

Also known as: Oropharyngeal Cancer / Cancer of Oropharnyx

IndicationStatusPhase
DBCOND0042409 (Oropharyngeal Cancers)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02298595Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaTreatment